Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects

Clinical trial NCT01442831 · COMPLETED

Trial details

NCT number

NCT01442831

Sponsor

Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2010-09-09

Primary completion

2010-09-22

Enrollment

6

View on ClinicalTrials.gov